Immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies, in a patient with melanoma treated with BRAF/MEK inhibitors

Castells, MR; Veiga, CGL; Fernandez-Morales, LA; Martinez, CE; Sanchez, SS; Zurita, NL; Vicente, CC; Cobo, PA; Boadas, MS; Garcia, YG; Palmer, MAS

Castells, MR (通讯作者),Parc Tauli Hosp, Dept Med Oncol, Sabadell, Barcelona, Spain.

MELANOMA RESEARCH, 2022; 32 (4): 299

Abstract

The effect of serine/threonine-protein kinase B-Raf/mitogen-activated protein kinase (BRAF/MEK) inhibitors on the immune system is not clearly describ......

Full Text Link